Oil & Gas Exploration & Production
Compare Stocks
5 / 10Stock Comparison
GFR vs CVE vs SU vs MEG vs XOM
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Waste Management
Oil & Gas Integrated
GFR vs CVE vs SU vs MEG vs XOM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Integrated | Oil & Gas Integrated | Waste Management | Oil & Gas Integrated |
| Market Cap | $410M | $53.60B | $75.67B | $798M | $620.85B |
| Revenue (TTM) | $563M | $49.40B | $52.01B | $821M | $323.90B |
| Net Income (TTM) | $-101M | $4.64B | $6.33B | $6M | $28.84B |
| Gross Margin | 22.7% | 19.6% | 55.5% | 39.0% | 21.7% |
| Operating Margin | 10.7% | 14.0% | 27.4% | 2.0% | 10.5% |
| Forward P/E | 16.6x | 7.5x | 7.7x | 172.3x | 14.8x |
| Total Debt | $6M | $17.00B | $18.37B | $359M | $43.54B |
| Cash & Equiv. | $42M | $2.74B | $3.65B | $11M | $10.68B |
GFR vs CVE vs SU vs MEG vs XOM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 23 | May 26 | Return |
|---|---|---|---|
| Greenfire Resources… (GFR) | 100 | 114.3 | +14.3% |
| Cenovus Energy Inc. (CVE) | 100 | 136.7 | +36.7% |
| Suncor Energy Inc. (SU) | 100 | 185.4 | +85.4% |
| Montrose Environmen… (MEG) | 100 | 71.9 | -28.1% |
| Exxon Mobil Corpora… (XOM) | 100 | 124.6 | +24.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GFR vs CVE vs SU vs MEG vs XOM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GFR is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.05, Low D/E 0.5%, current ratio 1.56x
- Beta 0.05 vs MEG's 1.82, lower leverage
CVE carries the broadest edge in this set and is the clearest fit for defensive.
- Beta 0.22, yield 2.0%, current ratio 1.57x
- Lower P/E (7.5x vs 14.8x)
- +147.0% vs GFR's +43.7%
- 7.8% ROA vs GFR's -7.8%, ROIC 7.9% vs 3.9%
SU ranks third and is worth considering specifically for long-term compounding.
- 197.4% 10Y total return vs CVE's 118.2%
- 12.2% margin vs GFR's -17.9%
MEG is the clearest fit if your priority is growth exposure.
- Rev growth 19.3%, EPS growth 93.7%, 3Y rev CAGR 15.1%
- 19.3% revenue growth vs GFR's -27.4%
XOM is the clearest fit if your priority is income & stability.
- Dividend streak 26 yrs, beta -0.15, yield 2.7%
- 2.7% yield, 26-year raise streak, vs CVE's 2.0%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.3% revenue growth vs GFR's -27.4% | |
| Value | Lower P/E (7.5x vs 14.8x) | |
| Quality / Margins | 12.2% margin vs GFR's -17.9% | |
| Stability / Safety | Beta 0.05 vs MEG's 1.82, lower leverage | |
| Dividends | 2.7% yield, 26-year raise streak, vs CVE's 2.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +147.0% vs GFR's +43.7% | |
| Efficiency (ROA) | 7.8% ROA vs GFR's -7.8%, ROIC 7.9% vs 3.9% |
GFR vs CVE vs SU vs MEG vs XOM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
GFR vs CVE vs SU vs MEG vs XOM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SU leads in 1 of 6 categories
MEG leads 1 • XOM leads 1 • GFR leads 0 • CVE leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SU leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 575.1x GFR's $563M. SU is the more profitable business, keeping 12.2% of every revenue dollar as net income compared to GFR's -17.9%. On growth, SU holds the edge at +25.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $563M | $49.4B | $52.0B | $821M | $323.9B |
| EBITDAEarnings before interest/tax | $144M | $12.4B | $21.7B | $67M | $59.9B |
| Net IncomeAfter-tax profit | -$101M | $4.6B | $6.3B | $6M | $28.8B |
| Free Cash FlowCash after capex | -$26M | $4.4B | $7.2B | $72M | $23.6B |
| Gross MarginGross profit ÷ Revenue | +22.7% | +19.6% | +55.5% | +39.0% | +21.7% |
| Operating MarginEBIT ÷ Revenue | +10.7% | +14.0% | +27.4% | +2.0% | +10.5% |
| Net MarginNet income ÷ Revenue | -17.9% | +9.4% | +12.2% | +0.7% | +8.9% |
| FCF MarginFCF ÷ Revenue | -4.6% | +8.8% | +13.9% | +8.7% | +7.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -20.8% | -12.8% | +25.1% | -5.2% | -1.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.6% | +78.7% | +30.1% | +45.3% | -11.0% |
Valuation Metrics
MEG leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, GFR trades at a 45% valuation discount to XOM's 21.9x P/E. On an enterprise value basis, SU's 5.1x EV/EBITDA is more attractive than MEG's 18.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $410M | $53.6B | $75.7B | $798M | $620.8B |
| Enterprise ValueMkt cap + debt − cash | $383M | $64.1B | $86.5B | $1.1B | $653.7B |
| Trailing P/EPrice ÷ TTM EPS | 12.07x | 18.06x | 17.93x | -157.64x | 21.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.65x | 7.47x | 7.73x | 172.29x | 14.79x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.99x | 8.91x | 5.13x | 18.04x | 10.91x |
| Price / SalesMarket cap ÷ Revenue | 0.97x | 1.47x | 2.11x | 0.96x | 1.92x |
| Price / BookPrice ÷ Book value/share | 0.48x | 2.24x | 2.35x | 1.72x | 2.37x |
| Price / FCFMarket cap ÷ FCF | 23.05x | 21.48x | 14.92x | 8.76x | 26.29x |
Profitability & Efficiency
Evenly matched — GFR and CVE and SU each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
CVE delivers a 15.2% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-10 for GFR. GFR carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MEG's 0.80x. On the Piotroski fundamental quality scale (0–9), CVE scores 6/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.0% | +15.2% | +14.0% | +1.3% | +10.7% |
| ROA (TTM)Return on assets | -7.8% | +7.8% | +7.0% | +0.6% | +6.4% |
| ROICReturn on invested capital | +3.9% | +7.9% | +20.1% | +1.3% | +8.6% |
| ROCEReturn on capital employed | +5.5% | +8.2% | +19.5% | +1.5% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 6 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.01x | 0.54x | 0.41x | 0.80x | 0.16x |
| Net DebtTotal debt minus cash | -$36M | $14.3B | $14.7B | $348M | $32.9B |
| Cash & Equiv.Liquid assets | $42M | $2.7B | $3.6B | $11M | $10.7B |
| Total DebtShort + long-term debt | $6M | $17.0B | $18.4B | $359M | $43.5B |
| Interest CoverageEBIT ÷ Interest expense | 0.48x | 11.80x | 11.68x | 4.67x | 69.44x |
Total Returns (Dividends Reinvested)
Evenly matched — CVE and SU each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVE five years ago would be worth $38,679 today (with dividends reinvested), compared to $3,853 for MEG. Over the past 12 months, CVE leads with a +147.0% total return vs GFR's +43.7%. The 3-year compound annual growth rate (CAGR) favors SU at 31.8% vs GFR's -19.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +17.7% | +63.2% | +40.8% | -11.3% | +20.3% |
| 1-Year ReturnPast 12 months | +43.7% | +147.0% | +92.7% | +46.6% | +43.9% |
| 3-Year ReturnCumulative with dividends | -47.5% | +85.3% | +128.8% | -27.2% | +44.9% |
| 5-Year ReturnCumulative with dividends | -47.5% | +286.8% | +201.0% | -61.5% | +164.6% |
| 10-Year ReturnCumulative with dividends | -47.5% | +118.2% | +197.4% | -1.4% | +105.0% |
| CAGR (3Y)Annualised 3-year return | -19.4% | +22.8% | +31.8% | -10.1% | +13.2% |
Risk & Volatility
Evenly matched — CVE and XOM each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than MEG's 1.82 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVE currently trades 92.3% from its 52-week high vs MEG's 69.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 0.22x | -0.03x | 1.82x | -0.15x |
| 52-Week HighHighest price in past year | $7.06 | $30.84 | $70.29 | $32.00 | $176.41 |
| 52-Week LowLowest price in past year | $3.81 | $11.60 | $33.50 | $14.92 | $101.19 |
| % of 52W HighCurrent price vs 52-week peak | +80.2% | +92.3% | +90.7% | +69.0% | +83.0% |
| RSI (14)Momentum oscillator 0–100 | 42.6 | 63.0 | 48.7 | 46.8 | 42.4 |
| Avg Volume (50D)Average daily shares traded | 239K | 13.1M | 4.6M | 332K | 18.9M |
Analyst Outlook
XOM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GFR as "Buy", CVE as "Hold", SU as "Buy", MEG as "Buy", XOM as "Hold". Consensus price targets imply 123.5% upside for MEG (target: $49) vs -2.8% for CVE (target: $28). For income investors, XOM offers the higher dividend yield at 2.73% vs MEG's 0.54%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $27.67 | $62.00 | $49.33 | $160.43 |
| # AnalystsCovering analysts | 1 | 27 | 31 | 12 | 55 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% | +2.6% | +0.5% | +2.7% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 4 | 0 | 26 |
| Dividend / ShareAnnual DPS | — | $0.78 | $2.30 | $0.12 | $4.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.4% | +3.0% | +15.3% | +3.3% |
SU leads in 1 of 6 categories (Income & Cash Flow). MEG leads in 1 (Valuation Metrics). 3 tied.
GFR vs CVE vs SU vs MEG vs XOM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GFR or CVE or SU or MEG or XOM a better buy right now?
For growth investors, Montrose Environmental Group, Inc.
(MEG) is the stronger pick with 19. 3% revenue growth year-over-year, versus -27. 4% for Greenfire Resources Ltd. (GFR). Greenfire Resources Ltd. (GFR) offers the better valuation at 12. 1x trailing P/E (16. 6x forward), making it the more compelling value choice. Analysts rate Greenfire Resources Ltd. (GFR) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GFR or CVE or SU or MEG or XOM?
On trailing P/E, Greenfire Resources Ltd.
(GFR) is the cheapest at 12. 1x versus Exxon Mobil Corporation at 21. 9x. On forward P/E, Cenovus Energy Inc. is actually cheaper at 7. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — GFR or CVE or SU or MEG or XOM?
Over the past 5 years, Cenovus Energy Inc.
(CVE) delivered a total return of +286. 8%, compared to -61. 5% for Montrose Environmental Group, Inc. (MEG). Over 10 years, the gap is even starker: SU returned +197. 4% versus GFR's -47. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GFR or CVE or SU or MEG or XOM?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Montrose Environmental Group, Inc. 's 1. 82β — meaning MEG is approximately -1346% more volatile than XOM relative to the S&P 500. On balance sheet safety, Greenfire Resources Ltd. (GFR) carries a lower debt/equity ratio of 1% versus 80% for Montrose Environmental Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GFR or CVE or SU or MEG or XOM?
By revenue growth (latest reported year), Montrose Environmental Group, Inc.
(MEG) is pulling ahead at 19. 3% versus -27. 4% for Greenfire Resources Ltd. (GFR). On earnings-per-share growth, the picture is similar: Montrose Environmental Group, Inc. grew EPS 93. 7% year-over-year, compared to -62. 4% for Greenfire Resources Ltd.. Over a 3-year CAGR, MEG leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GFR or CVE or SU or MEG or XOM?
Suncor Energy Inc.
(SU) is the more profitable company, earning 12. 1% net margin versus -0. 1% for Montrose Environmental Group, Inc. — meaning it keeps 12. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SU leads at 31. 7% versus 1. 5% for MEG. At the gross margin level — before operating expenses — SU leads at 59. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GFR or CVE or SU or MEG or XOM more undervalued right now?
On forward earnings alone, Cenovus Energy Inc.
(CVE) trades at 7. 5x forward P/E versus 172. 3x for Montrose Environmental Group, Inc. — 164. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MEG: 123. 5% to $49. 33.
08Which pays a better dividend — GFR or CVE or SU or MEG or XOM?
In this comparison, XOM (2.
7% yield), SU (2. 6% yield), CVE (2. 0% yield), MEG (0. 5% yield) pay a dividend. GFR does not pay a meaningful dividend and should not be held primarily for income.
09Is GFR or CVE or SU or MEG or XOM better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Montrose Environmental Group, Inc. (MEG) carries a higher beta of 1. 82 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XOM: +105. 0%, MEG: -1. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GFR and CVE and SU and MEG and XOM?
These companies operate in different sectors (GFR (Energy) and CVE (Energy) and SU (Energy) and MEG (Industrials) and XOM (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GFR is a small-cap deep-value stock; CVE is a mid-cap quality compounder stock; SU is a mid-cap deep-value stock; MEG is a small-cap high-growth stock; XOM is a large-cap quality compounder stock. CVE, SU, MEG, XOM pay a dividend while GFR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.